Prebiotic oligosaccharides in premature infants

Journal of Pediatric Gastroenterology and Nutrition

Volumn 58, Issue 3, 2014, Pages 352-360

  Underwood, Mark A ^a   Kalanetra, Karen M ^a   Bokulich, Nicholas A ^a   Mirmiran, Majid ^a   Barile, Daniela ^a   Tancredi, Daniel J ^a   German, J Bruce ^a   Lebrilla, Carlito B ^b   Mills, David A ^a  

^a Department of Pediatrics ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

All human diet; Galacto oligosaccharide; Human milk oligosaccharide; Late onset sepsis; Necrotizing enterocolitis

Indexed keywords

ANTIBIOTIC AGENT; GALACTOSE OLIGOSACCHARIDE; PREBIOTIC AGENT;

ARTICLE; ARTIFICIAL MILK; BIFIDOBACTERIACEAE; BREAST MILK; CHILD SAFETY; CLINICAL ARTICLE; CLOSTRIDIA; CONTROLLED STUDY; DELTAPROTEOBACTERIA; FECES ANALYSIS; FECES MICROFLORA; FEMALE; HUMAN; INFANT; INTESTINE FLORA; MALE; NUTRITIONAL INTOLERANCE; POLYMERASE CHAIN REACTION; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

BACTERIA (MICROORGANISMS); BOVINAE; CLOSTRIDIA; GAMMAPROTEOBACTERIA;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL TYPING TECHNIQUES; BIFIDOBACTERIUM; CATTLE; CLOSTRIDIUM; FEMALE; FOOD, FORTIFIED; HUMANS; INFANT; INFANT FORMULA; INFANT, NEWBORN; INFANT, PREMATURE; INTESTINES; LACTOBACILLUS; MALE; MILK, HUMAN; OLIGOSACCHARIDES; PREBIOTICS; PROTEOBACTERIA;

EID: 84896702139     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000000211     Document Type: Article

References (51)

1. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011; 364:255-64
2. Marin T, Strickland OL. Transfusion-related necrotizing enterocolitis: A conceptual framework. Adv Neonatal Care 2013;13:166-74
3. Downard CD, Grant SN, Maki AC, et al. Maternal cigarette smoking and the development of necrotizing enterocolitis. Pediatrics 2012;130:78-82
4. Morrow AL, Meinzen-Derr J, Huang P, et al. Fucosyltransferase 2 nonsecretor and low secretor status predicts severe outcomes in premature infants. J Pediatr 2011;158:745-51
5. Morgan J, Young L, McGuire W. Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst Rev 2011:CD001241
6. Schanler RJ. Outcomes of human milk-fed premature infants. Semin Perinatol 2011;35:29-33
7. Quigley MA, Henderson G, Anthony MY, et al. Formula milk versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev 2007:CD002971
8. Deshpande G, Rao S, Patole S, et al. Updated meta-Analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010;125:921-30
9. Sullivan S, Schanler RJ, Kim JH, et al. An exclusively human milkbased diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr 2010;156:562-7
10. Ganapathy V, Hay JW, Kim JH. Costs of necrotizing enterocolitis and cost-effectiveness of exclusively human milk-based products in feeding extremely premature infants. Breastfeed Med 2012;7:29-37
11. Zivkovic AM, German JB, Lebrilla CB, et al. Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proc Natl Acad Sci U S A 2011;108 (suppl 1):4653-8
12. Kim JH, An HJ, Garrido D, et al. Proteomic analysis of Bifidobacterium longum subsp. infantis reveals the metabolic insight on consumption of prebiotics and host glycans. PLoS One 2013;8:e57535
13. Srinivasjois R, Rao S, Patole S. Prebiotic supplementation in preterm neonates: Updated systematic review and meta-Analysis of randomised controlled trials. Clin Nutr 2013;32:958-65
14. Campbell MJ, Julious SA, Altman DG. Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ 1995;311:1145-8
15. NinonuevoMR, Lebrilla CB. Mass spectrometric methods for analysis of oligosaccharides in human milk. Nutr Rev 2009;67 (suppl 2):S216-26
16. Meyrand M, Caillat H, Bouvier F, et al. Comparison of milk oligosaccharides between goats with and without the genetic ability to synthesize alpha s1-casein. Small Ruminant Res 2013;113:411-20
17. Underwood MA, Kalanetra KM, Bokulich NA, et al. A comparison of two probiotic strains of bifidobacteria in premature infants. J Pediatr 2013;163:1585-91
18. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-Throughput community sequencing data. Nat Methods 2010; 7:335-6
19. SAS [computer program]. Version 9.2 Cary, NC: SAS Institute Inc; 2002
20. Mancl LA, DeRouen TA. A covariance estimator for GEE with improved small-sample properties. Biometrics 2001;57:126-34
21. Ferrari SLP, Cribari-Neto F. Beta regression for modelling rates and proportions. J Appl Stat 2004;31:799-815
22. Jost L. Entropy and diversity. Oikos 2006;113:363-75
23. Westerbeek EA, Morch E, Lafeber HN, et al. Effect of neutral and acidic oligosaccharides on fecal IL-8 and fecal calprotectin in preterm infants. Pediatr Res 2011;69:255-8
24. Jacquot A, Neveu D, Aujoulat F, et al. Dynamics and clinical evolution of bacterial gut microflora in extremely premature patients. J Pediatr 2011;158:390-6
25. Westerbeek EA, van den Berg JP, Lafeber HN, et al. Neutral and acidic oligosaccharides in preterm infants: A randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2010;91:679-86
26. Sela DA, Mills DA. Nursing our microbiota: Molecular linkages between bifidobacteria and milk oligosaccharides. Trends Microbiol 2010;18:298-307
27. Newburg DS, Ruiz-Palacios GM, Morrow AL. Human milk glycans protect infants against enteric pathogens. Annu Rev Nutr 2005;25:37-58
28. Wang B. Sialic acid is an essential nutrient for brain development and cognition. Annu Rev Nutr 2009;29:177-222
29. Chichlowski M, German JB, Lebrilla CB, et al. The influence of milk oligosaccharides on microbiota of infants: Opportunities for formulas. Annu Rev Food Sci Technol 2011;2:331-51
30. Mehta R, Petrova A. Biologically active breast milk proteins in association with very preterm delivery and stage of lactation. J Perinatol 2011;31:58-62
31. De Leoz ML, Gaerlan SC, Strum JS, et al. Lacto-N-Tetraose, fucosylation, and secretor status are highly variable in human milk oligosaccharides from women delivering preterm. J Proteome Res 2012; 11:4662-72
32. Fanaro S, Chierici R, Guerrini P, et al. Intestinal microflora in early infancy: Composition and development. Acta Paediatr Suppl 2003; 91:48-55
33. Mshvildadze M, Neu J, Shuster J, et al. Intestinal microbial ecology in premature infants assessed with non-culture-based techniques. J Pediatr 2010;156:20-5
34. Westerbeek EA, van den Berg A, Lafeber HN, et al. The intestinal bacterial colonisation in preterm infants: A review of the literature. Clin Nutr 2006;25:361-8
35. Cotten CM, Taylor S, Stoll B, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009;123:58-66
36. Alexander VN, Northrup V, Bizzarro MJ. Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J Pediatr 2011;159:392-7
37. Kuppala VS, Meinzen-Derr J, Morrow AL, et al. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr 2011;159:720-5
38. Wang Y, Hoenig JD, Malin KJ, et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. Isme J 2009;3:944-54
39. Mai V, Young CM, Ukhanova M, et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS One 2011; 6:e20647
40. Jantscher-Krenn E, Zherebtsov M, Nissan C, et al. The human milk oligosaccharide disialyllacto-N-Tetraose prevents necrotising enterocolitis in neonatal rats. Gut 2012;61:1417-25
41. Marini A, Negretti F, Boehm G, et al. Pro-And pre-biotics administration in preterm infants: Colonization and influence on faecal flora. Acta Paediatr Suppl 2003;91:80-1
42. Westerbeek EA, Slump RA, Lafeber HN, et al. The effect of enteral supplementation of specific neutral and acidic oligosaccharides on the faecal microbiota and intestinal microenvironment in preterm infants. Eur J Clin Microbiol Infect Dis 2013;32:269-76
43. Modi N, Uthaya S, Fell J, et al. A randomized, double-blind, controlled trial of the effect of prebiotic oligosaccharides on enteral tolerance in preterm infants (ISRCTN77444690). Pediatr Res 2010; 68:440-5
44. Knol J, Boehm G, Lidestri M, et al. Increase of faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants. Acta Paediatr Suppl 2005;94:31-3
45. Garrido D, Ruiz-Moyano S, Jimenez-Espinoza R, et al. Utilization of galactooligosaccharides by Bifidobacterium longum subsp. infantis isolates. Food Microbiol 2013;33:262-70
46. Bakker-Zierikzee AM, Tol EA, Kroes H, et al. Faecal SIgA secretion in infants fed on pre-or probiotic infant formula. Pediatr Allergy Immunol 2006;17:134-40
47. Tuovinen E, Keto J, Nikkila J, et al. Cytokine response of human mononuclear cells induced by intestinal Clostridium species. Anaerobe 2013;19:70-6
48. Partty A, Luoto R, Kalliomaki M, et al. Effects of early prebiotic and probiotic supplementation on development of gut microbiota and fussing and crying in preterm infants: A randomized, double-blind, placebo-controlled trial. J Pediatr 2013;163:1272-7
49. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008; 105:16731-6
50. Dittmar E, Beyer P, Fischer D, et al. Necrotizing enterocolitis of the neonate with Clostridium perfringens: Diagnosis, clinical course, and role of alpha toxin. Eur J Pediatr 2008;167:891-5
51. Makelainen H, Saarinen M, Stowell J, et al. Xylo-oligosaccharides and lactitol promote the growth of Bifidobacterium lactis and Lactobacillus species in pure cultures. Benef Microbes 2010;1:139-48